Cargando…
Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer
Low response rate and recurrence are common issues in lung cancer; thus, identifying a potential compound for these patients is essential. Utilizing an in silico screening method, we identified withaferin A (WA), a cell-permeable steroidal lactone initially extracted from Withania somnifera, as a po...
Autores principales: | Hsu, Jade H.-M., Chang, Peter M.-H., Cheng, Tai-Shan, Kuo, Yu-Lun, Wu, Alexander T.-H., Tran, Thu-Ha, Yang, Yun-Hsuan, Chen, Jing-Ming, Tsai, Yu-Chen, Chu, Yeh-Shiu, Huang, Tse- Hung, Huang, Chi-Ying F., Lai, Jin-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678286/ https://www.ncbi.nlm.nih.gov/pubmed/31319622 http://dx.doi.org/10.3390/cancers11071003 |
Ejemplares similares
-
Withaferin A: From Ancient Remedy to Potential Drug Candidate
por: Sultana, Tahira, et al.
Publicado: (2021) -
Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells
por: Chang, Hsueh-Wei, et al.
Publicado: (2017) -
Withaferin a Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress
por: Chien, Tsu-Ming, et al.
Publicado: (2021) -
Withaferin A attenuates ovarian cancer-induced cardiac cachexia
por: Kelm, Natia Q., et al.
Publicado: (2020) -
Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
por: Malik, Vidhi, et al.
Publicado: (2022)